The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) — Stella

Recruiting

Back to Coronary Artery Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(40 sites)

United States

Cedars-Sinai, Los Angeles, California

Yale University, New Haven, Connecticut

UofL Health, Inc, Louisville, Kentucky

John Hopkins Hospital, Baltimore, Maryland

Mayo Clinic, Rochester, Minnesota

Key details

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

Canadian Institutes of Health Research (CIHR), Weill Medical College of Cornell University

Enrollment target

~754 participants

Started

June 2023

Primary completion

April 2029

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.